Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

186.26 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Treasury Secretary Declares 'Housing Recession,' Pressures Fed for Immediate Rate Cuts
In a stark warning echoing through the financial markets, U.S. Treasury Secretary Scott Bessent declared this week that the American housing sector is already mired in a recession, directly attributing... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Options Corner: Kimberly-Clark's Implosion Offers An Unusual Informational Arbitrage Opportunity
Although Kimberly-Clark suffered a huge blow after announcing its Kenvue buyout, KMB stock is flashing a quantitative contrarian signal. 
Via Benzinga
Gold Edges Higher; ISM Manufacturing PMI Falls In October
 
Via Benzinga
Tech Titans Unite and Consumer Giants Merge: Amazon-OpenAI Partnership and Kenvue Buyout Ignite S&P 500 and Nasdaq Gains
November 3, 2025 – The U.S. stock markets are experiencing a significant surge today, with both the S&P 500 and Nasdaq Composite pushing towards new highs. This bullish sentiment is largely fueled by... 
Via MarketMinute
Topics Artificial Intelligence Lawsuit Stocks
Alvotech Shares Plunge 33% After FDA Flags Issues
Alvotech shares decline after the FDA issues a complete response letter for its Simponi biosimilar, leading to a lower 2025 revenue and EBITDA outlook. 
Via Benzinga
Kenvue's Megadeal Fuels Stock Market Rise at Week's Start: A New Consumer Health Giant Emerges
The financial markets have kicked off the week with a significant surge, largely propelled by the blockbuster acquisition of Kenvue Inc. (NYSE: KVUE) by Kimberly-Clark Corporation (NYSE: KMB). This... 
Via MarketMinute
Topics Supply Chain
Tech Titans and Consumer Giants Reshape Markets: Amazon's AI Leap and Kimberly-Clark's Mega-Merger
November 3, 2025, marks a pivotal day in the financial markets, witnessing two seismic corporate announcements that promise to redefine their respective industries. Amazon.com Inc. (NASDAQ: AMZN) has... 
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
Buffett Sells Stocks – Here Is What Prudent Investors Should Do Now; OPEC+ Changes Stance
Buffett Sells Stocks Please click here for a chart of Warren Buffett’s company Berkshire Hathaway Inc Class B (NYSE: 
Via Benzinga
Dow Jones Extends Gains as Palantir Eyes AI-Driven Surge and Kenvue Soars on Kimberly-Clark Takeover
New York, NY – November 3, 2025 – The Dow Jones Industrial Average is on track to extend its robust gains as the market closes out a strong trading day, buoyed by a confluence of positive factors... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Kimberly-Clark Stock Plunges Over 16%, Kenvue Surges 20% In Monday Pre-Market: What's Going On?
Shares of Kimberly-Clark Corporation (NASDAQ: KMB) plunged 16.49% during the pre-market trading session on Monday, after it announced the acquisition of Kenvue Inc. (NYSE: KVUE). 
Via Benzinga
Will President Trump's Tylenol Claims Hurt These 2 Leading Pharmaceutical Stocks?
Even though Kenvue's stock was already in a tailspin before the FDA warned pregnant woman that Tylenol posed a health risk, there are still some lingering impacts to consider. 
Via The Motley Fool
Topics Government
Johnson & Johnson Stock: Is Wall Street Bullish or Bearish?
Johnson & Johnson has delivered a standout performance in 2025, outperforming both the broader market and the healthcare sector. Analysts continue to be fairly bullish on the stock’s trajectory. 
Via Barchart.com
Amgen Solidifies Biotech Dividend Prowess with $2.38 Q4 2025 Payout
Thousand Oaks, CA – October 31, 2025 – Amgen (NASDAQ: AMGN), a leading biotechnology giant, has declared a quarterly dividend of $2.38 per share for the fourth quarter of 2025. This significant... 
Via MarketMinute
Topics Intellectual Property
AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs
San Francisco, CA – October 31, 2025 – Artificial intelligence (AI) is ushering in a transformative era for the pharmaceutical industry, particularly in the often-overlooked yet critical domain of... 
Via TokenRing AI
Topics Artificial Intelligence Supply Chain
AI Revolutionizes Pharma R&D: A New Era of Accelerated Drug Discovery and Personalized Medicine
Artificial intelligence (AI) is ushering in a transformative era for pharmaceutical research and development (R&D), fundamentally reshaping how new medicines are discovered, developed, and brought to... 
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property
AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future
The pharmaceutical industry is in the midst of a profound and rapid transformation, driven by the pervasive integration of Artificial Intelligence (AI). What was once a futuristic concept is, by late... 
Via TokenRing AI
Topics Animal Testing Artificial Intelligence Economy
Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
Via MarketBeat
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain
As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the GLP-1 gold rush. 
Via Benzinga
Topics ETFs
Navigating the Aftermath: What Lies Ahead for Markets Post-Decline
The financial markets are grappling with the reverberations of a significant day of declines, leaving investors and analysts alike pondering the immediate and long-term trajectory. This recent downturn... 
Via MarketMinute
Topics Economy Stocks
From Record Heights to Pullback: Analyzing the Current Market Correction
The global financial markets, which had soared to unprecedented valuations through late 2024 and early 2025, experienced a sharp and unsettling correction in April 2025. This significant downturn,... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
S&P 500 Healthcare Sector Navigates Mixed Market Waters on October 29, 2025
On October 29, 2025, the broader market exhibited a decidedly mixed performance, reflecting a prevailing sense of uncertainty among investors. Against this backdrop of fluctuating sentiment, the S&P... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Navigating the Aftermath: Market Outlook Post-Declines Amidst Trade Truce and Rate Uncertainty
The global financial markets, as of October 30, 2025, are grappling with a complex interplay of factors, following a day characterized by stock futures pointing to a lower open and investor caution.... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
S&P 500: Decoding the Daily Market Pulse on October 29, 2025
As the trading day of October 29, 2025, draws to a close, investors and analysts alike are keenly focused on the S&P 500, the bellwether index for the U.S. stock market. Representing 500 of the largest... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
Market Mania: Soaring Investor Confidence Propels Global Indices to Uncharted Heights
As October 29, 2025, dawns, financial markets are awash with an extraordinary wave of investor confidence, a sentiment so potent it is propelling major global indices to unprecedented record highs.... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Navigating the Financial Tides: An Investor's Timeless Guide to Bull and Bear Markets
In the dynamic world of financial markets, two iconic figures dominate the landscape: the Bull and the Bear. These powerful symbols represent the contrasting forces that drive asset prices, investor... 
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Bonds
Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOVA),(NYSE:MRK),(NYSE:LLY),(NYSE:JNJ) EQNX::TICKER_END 
Via FinancialNewsMedia
Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety
Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for pregnant women. 
Via Benzinga
Topics Lawsuit
Kenvue Stock Drops After Texas Attorney General Sues Company Alleging Deceptive Marketing Of Tylenol
The lawsuit comes on the heels of President Trump linking Tylenol to autism. 
Via Stocktwits
Topics Government Lawsuit
2 Dividend Stocks to Double Up on Right Now
They are about as safe as dividends can get. 
Via The Motley Fool
Topics Artificial Intelligence Economy
Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers
As the closing bell rings on October 27, 2025, the S&P 500 Healthcare sector stands at a critical juncture, exhibiting the nuanced volatility that defines this essential yet complex segment of the... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.